Robinson K - Search Results

1

Identification of Somatic Mitochondrial DNA Mutations, Heteroplasmy, and Increased Levels of Catenanes in Tumor Specimens Obtained from Three Endometrial Cancer Patients.

Young MJ, Sachidanandam R, Hales DB, Brard L, Robinson K, Rahman MM, Khadka P, Groesch K, Young CKJ. Young MJ, et al. Among authors: robinson k. Life (Basel). 2022 Apr 9;12(4):562. doi: 10.3390/life12040562. Life (Basel). 2022. PMID: 35455053 Free PMC article.

2

Single nucleotide variant in Nucleoporin 107 may be predictive of sensitivity to chemotherapy in patients with ovarian cancer.

Alanee S, Delfino K, Wilber A, Robinson K, Brard L, Semaan A. Alanee S, et al. Among authors: robinson k. Pharmacogenet Genomics. 2017 Jul;27(7):264-269. doi: 10.1097/FPC.0000000000000288. Pharmacogenet Genomics. 2017. PMID: 28562428 Free PMC article.

3

Renal cell tumors convert natural killer cells to a proangiogenic phenotype.

Guan Y, Chambers CB, Tabatabai T, Hatley H, Delfino KR, Robinson K, Alanee SR, Ran S, Torry DS, Wilber A. Guan Y, et al. Among authors: robinson k. Oncotarget. 2020 Jun 30;11(26):2571-2585. doi: 10.18632/oncotarget.27654. eCollection 2020 Jun 30. Oncotarget. 2020. PMID: 32655841 Free PMC article.

4

AKR1B10 as a Potential Novel Serum Biomarker for Breast Cancer: A Pilot Study.

Cao Z, Delfino K, Tiwari V, Wang X, Hannan A, Zaidi F, McClintock A, Robinson K, Zhu Y, Gao J, Cao D, Rao K. Cao Z, et al. Among authors: robinson k. Front Oncol. 2022 Feb 24;12:727505. doi: 10.3389/fonc.2022.727505. eCollection 2022. Front Oncol. 2022. PMID: 35280770 Free PMC article.

5

Impact of cytotoxic chemotherapy on aldo-keto reductase family 1 member B10 expression.

Robinson K, Cao Z, Delfino K, Cao D, Rao K. Robinson K, et al. J Int Med Res. 2023 Jun;51(6):3000605231179317. doi: 10.1177/03000605231179317. J Int Med Res. 2023. PMID: 37389562 Free PMC article.

6

First Report of ARID1A Somatic Mutation in a Female Patient With Renal Cell Carcinoma.

Clemons J, Robinson K, Alanee S. Clemons J, et al. Among authors: robinson k. Clin Genitourin Cancer. 2016 Apr;14(2):e229-31. doi: 10.1016/j.clgc.2015.12.024. Epub 2015 Dec 28. Clin Genitourin Cancer. 2016. PMID: 26786561 No abstract available.

7

Characterization of immortalized human mammary epithelial cell line HMEC 2.6.

Joshi PS, Modur V, Cheng J, Robinson K, Rao K. Joshi PS, et al. Among authors: robinson k. Tumour Biol. 2017 Oct;39(10):1010428317724283. doi: 10.1177/1010428317724283. Tumour Biol. 2017. PMID: 29022488 Free article.

8

Quality of life following treatment with intra-arterial cisplatin with concurrent radiation and erlotinib for locally advanced head and neck cancer.

Cossyleon R, Robinson K, Delfino K, Robbins KT, Rao K. Cossyleon R, et al. Among authors: robinson k. Support Care Cancer. 2024 Jan 9;32(2):93. doi: 10.1007/s00520-023-08286-1. Support Care Cancer. 2024. PMID: 38193937 Free PMC article.

9

Immune Characterization of the Programmed Death Receptor Pathway in High Risk Prostate Cancer.

Baas W, Gershburg S, Dynda D, Delfino K, Robinson K, Nie D, Yearley JH, Alanee S. Baas W, et al. Among authors: robinson k. Clin Genitourin Cancer. 2017 Oct;15(5):577-581. doi: 10.1016/j.clgc.2017.04.002. Epub 2017 Apr 10. Clin Genitourin Cancer. 2017. PMID: 28461179

10

A phase II study of intra-arterial cisplatin with concurrent radiation and erlotinib for locally advanced head and neck cancer.

Rao K, Kalapurakal S, Chalasani P, Robinson K, Malone J, Clausen C, Ronen O, Dhiwakar M, Shevlin B, Robbins KT. Rao K, et al. Among authors: robinson k. Cancer Chemother Pharmacol. 2013 Sep;72(3):545-52. doi: 10.1007/s00280-013-2225-7. Epub 2013 Jul 25. Cancer Chemother Pharmacol. 2013. PMID: 23884559 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,640 results

Search Page